COMMUNIQUÉS West-GlobeNewswire

Oxford BioMedica plc: INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2017

17/08/2017 - 13:00

OXFORD BIOMEDICA PLC INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2017 Oxford, UK - 17 August 2017: Oxford BioMedica plc ("OXB" or "the Group"; LSE: OXB), a leading gene and cell therapy group, today announces [...]

RedHill Biopharma Announces U.S. Commercialization Agreement for FDA-Approved GI Product Esomeprazole Strontium Delayed-Release Capsules

17/08/2017 - 13:00

RedHill was granted the exclusive rights to promote Esomeprazole Strontium Delayed-Release (DR) Capsules to gastroenterologists in certain U.S. territories Esomeprazole Strontium DR Capsules 49.3 mg is an FDA-approved, [...]

Aptevo Therapeutics and Alligator Bioscience commence IND-enabling development activities for new bispecific immunotherapy candidate ALG.APV-527

17/08/2017 - 13:00

Aptevo Therapeutics and Alligator Bioscience commence IND-enabling development activities for new bispecific immunotherapy candidate ALG.APV-527 Novel Bispecific Antibody Targeting Biological Pathway Implicated in [...]

Immunicum AB (publ) Completes Strategic Analysis and Defines Updated Clinical Development Plan for Ilixadencel

17/08/2017 - 08:00

Press Release 17 August 2017 Immunicum Completes Strategic Analysis and Defines Updated Clinical Development Plan for Ilixadencel Immunicum AB (publ; First North Premier: IMMU.ST), a biopharmaceutical company advancing [...]

argenx to host conference call & webcast to report second quarter business update and half year 2017 financial results on August 24, 2017

17/08/2017 - 07:00

Breda, the Netherlands / Ghent, Belgium - argenx (Euronext & Nasdaq: ARGX), a clinical-stage biotechnology company developing a deep pipeline of differentiated antibody-based therapies for the treatment of severe [...]

ABLYNX WILL ANNOUNCE ITS 2017 HALF YEAR RESULTS WITH WEBCAST ON 24 AUGUST 2017

17/08/2017 - 07:00

GHENT, Belgium, 17 August 2017 - Ablynx [Euronext Brussels: ABLX; OTC: ABYLY] will report its 2017 half year financial results and year-to-date business update on Thursday 24 August 2017 at 7.00 am CET. The Ablynx [...]

Semaglutide superior to dulaglutide on glucose control and weight loss in people with type 2 diabetes in SUSTAIN 7

16/08/2017 - 20:01

Bagsværd , Denmark, 16 August 2017 - Novo Nordisk today announced the SUSTAIN 7 trial results, demonstrating that people with type 2 diabetes treated with once-weekly semaglutide experienced superior reduction in HbA 1c [...]

CROSSJECT : Information relative au nombre total de droits de vote et d'actions composant le capital social

16/08/2017 - 17:57

Information relative au nombre total de droits de vote et d'actions composant le capital social 16 août 2017 CROSSJECT (ISIN : FR0011716265 ; Mnémo : ALCJ), « specialty pharma » qui développe un portefeuille de [...]

Abeona Therapeutics Announces Pivotal Expansion of ABO-102 Gene Therapy Clinical Trials in Sanfilippo Syndrome Type A

16/08/2017 - 15:37

NEW YORK and CLEVELAND, Aug. 16, 2017 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq:ABEO), a leading clinical-stage biopharmaceutical company focused on developing novel gene therapies for life-threatening rare [...]

Photocure ASA: Presentation of the second quarter and first half year 2017 results

16/08/2017 - 14:45

Photocure will present its second quarter and first half year report on Wednesday 23 August 2017 at Hotel Continental, Oslo, Norway. The presentation will begin at 08:30 (CET) and representatives from the company will [...]

Vascular Dynamics annonce l'approbation de la FDA pour le lancement de l'essai CALM 2 pour le MobiusHD® System pour le traitement de l'hypertension artérielle résistante

16/08/2017 - 12:58

MOUNTAIN VIEW, Californie, 15 août 2017 (GLOBE NEWSWIRE) - Vascular Dynamics, Inc. (VDI), société privée de dispositifs médicaux développant de nouvelles solutions pour le traitement de l'hypertension, annonce aujourd' [...]

Curetis Announces Financial Results for the First Six Months of 2017

16/08/2017 - 08:16

Curetis Announces Financial Results for the First Six Months of 2017 - Further advancement of product pipeline and integration of GEAR and Gyronimo platforms - Expansion of global installed base to 161 as of June 30, [...]

NEXSTIM PLC HALF-YEARLY REPORT 1 JANUARY - 30 JUNE 2017 (UNAUDITED)

16/08/2017 - 08:00

Company announcement, Helsinki, 16 August 2017 at 9:00 am Company Highlights, January - June 2017 Patient enrolment for Nexstim's supplementary Phase III Trial in Stroke Rehabilitation (E-FIT) using its NBT ® system is [...]

Ascom Myco and Koutio Médipôle optimize care communications and responsiveness

16/08/2017 - 08:00

Enabled by the Ascom Myco smart device, the new Koutio Médipôle is realizing improved care delivery through seamless information flow from the point of care to anywhere. BAAR, Switzerland, Aug. 16, 2017 (GLOBE NEWSWIRE [...]

New ThromboGenics' Ocriplasmin Clinical and Health Economic Data Presented at ASRS 2017 Annual Scientific Meeting in Boston

16/08/2017 - 07:30

Leuven, Belgium, 16 August 2017 - ThromboGenics NV (Euronext Brussels: THR), a biotechnology company developing novel treatments for diabetic eye disease, announced today that further ocriplasmin clinical and health [...]

Curetis Announces Management Board Changes

16/08/2017 - 07:13

Curetis Announces Management Board Changes - New roles for Andreas Boos, Chris Bernard and Dr. Achim Plum Amsterdam, the Netherlands, and Holzgerlingen, Germany, August 16, 2017; published at 7 am CET -- Curetis N.V. ( [...]

MDxHealth Notice of January-June 2017 Financial Results

16/08/2017 - 07:00

COMPANY ANNOUNCEMENT / REGULATED INFORMATION / INSIDE INFORMATION IRVINE, CA, and HERSTAL, BELGIUM - 07:00 CEST, August 16, 2017 - MDxHealth SA (Euronext: MDXH.BR) today announced that it will release its financial [...]

Avis de publication des résultats financiers de MDxHealth pour janvier-juin 2017

16/08/2017 - 07:00

Annonce d'entreprise / INFORMATION REGLEMENTAIRE / INFORMATION PRIVILEGIEE IRVINE, CALIFORNIE et HERSTAL, BELGIQUE - 07:00 CEST, le 16 août, 2017 - MDxHealth SA (Euronext: MDXH.BR) a annoncé la publication le jeudi 31 [...]

H1 2017: Tecan with significant increase in order entry and strong sales growth in the Life Sciences Business

16/08/2017 - 07:00

Financial results for the first half of 2017 Order entry of CHF 291.2 million (H1 2016: CHF 250.6 million) Growth of 16.7% in local currencies or 16.2% in Swiss francs Double-digit increase in both business segments [...]